Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Cavalli, G., De Luca, G., Campochiaro, C., Della-Torre, E., Ripa, M., Canetti, D., ... & Dagna, L. (2020). Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30127-2/fulltext
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Neurological Associations of COVID-19
Endothelial cell infection and endotheliitis in COVID-19
Clinical impact of COVID-19 on patients with cancer
Hyperinflammatory shock in children during the COVID-19 pandemic
COVID-19 Cytokine Storm: the interplay between inflammation and coagulation
COVID-19: consider cytokine storm syndrome and immunosuppression
Canakinumab in a subgroup of patients with COVID-19
Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study
Association between high serum total cortisol concentrations and mortality from COVID-19
Human recombinant soluble ACE2 in severe COVID-19 (Duplicate)